Although IgA-mediated anti-GBM disease is not a variant of atypical anti-GBM disease (because the deposited Ig in the GBM is IgA and not IgG), false-negative serology on conventional assays could initially mimic atypical anti-GBM disease. The gene discussed is CD79A; the disease is glioblastoma.